Citation Impact
3 from Science/Nature 76 standout
Citing Papers
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of Alison Innes being referenced
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
2005
Author Peers
| Author | Genetics | Epidemiology | Hematology | Immunology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Alison Innes | 485 | 403 | 97 | 167 | 9 | 637 | |
| Mei-Due Yang | 23 | 58 | 9 | 44 | 26 | 777 | |
| Scott A. Machtley | 110 | 2 | 2 | 32 | 455 | ||
| A. J. Hale | 1 | 16 | 483 | ||||
| Živilė Gudlevičienė | 8 | 99 | 3 | 37 | 31 | 238 | |
| Sören Frey | 13 | 131 |
All Works
Loading papers...